HK Stock MarketDetailed Quotes

CH BIOTECH SER (08037)

Watchlist
  • 0.670
  • 0.0000.00%
Market Closed Apr 30 15:59 CST
653.74MMarket Cap-9.57P/E (TTM)

CH BIOTECH SER (08037) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
4.25%73.5M
19.79%38.87M
-66.74%70.51M
-82.21%32.45M
-88.55%211.99M
-84.27%200.71M
-73.45%182.36M
-66.01%130.56M
196.83%1.85B
152.42%1.28B
Operating income
4.25%73.5M
19.79%38.87M
-66.74%70.51M
-82.21%32.45M
-88.55%211.99M
-84.27%200.71M
-73.45%182.36M
-66.01%130.56M
196.83%1.85B
152.42%1.28B
Cost of sales
12.82%-65.78M
-2.18%-36.33M
57.53%-75.45M
70.62%-35.56M
76.33%-177.66M
72.05%-150.79M
63.55%-121.03M
58.12%-81.4M
-182.45%-750.58M
-154.70%-539.44M
Operating expenses
12.82%-65.78M
-2.18%-36.33M
57.53%-75.45M
70.62%-35.56M
76.33%-177.66M
72.05%-150.79M
63.55%-121.03M
58.12%-81.4M
-182.45%-750.58M
-154.70%-539.44M
Gross profit
256.40%7.73M
181.82%2.54M
-114.39%-4.94M
-105.07%-3.11M
-96.88%34.32M
-93.22%49.92M
-82.72%61.33M
-74.09%49.16M
207.51%1.1B
150.78%736.31M
Selling expenses
29.39%-8.31M
44.56%-3.63M
19.41%-11.77M
10.01%-6.55M
-6.44%-14.61M
-4.09%-10.61M
32.06%-7.28M
4.74%-3.72M
-17.08%-13.73M
-11.87%-10.19M
Administrative expenses
40.77%-58.13M
52.06%-33.98M
29.06%-98.14M
8.85%-70.88M
42.63%-138.34M
30.99%-108.73M
17.12%-77.77M
17.71%-44.72M
-53.52%-241.16M
-49.38%-157.56M
Research and development expenses
48.36%-17.2M
66.09%-5.97M
---33.31M
---17.59M
----
----
----
----
----
----
Revaluation surplus
----
----
----
----
----
----
----
----
453.58%2.71M
--2.71M
-Changes in the fair value of financial assets
----
----
----
----
----
----
----
----
453.58%2.71M
--2.71M
Impairment and provision
104.39%30K
----
86.47%-684K
----
-195.04%-5.06M
----
----
----
-582.87%-1.71M
--859K
-Other impairment is provision
104.39%30K
----
86.47%-684K
----
-195.04%-5.06M
----
----
----
-582.87%-1.71M
--859K
Special items of operating profit
306.17%23.56M
182.12%21.73M
245.40%5.8M
-155.63%-26.46M
-185.99%-3.99M
-1,403.46%-13.89M
-367.33%-10.35M
-807.50%-1.82M
1,961.78%4.64M
-311.44%-924K
Operating profit
63.42%-52.33M
84.50%-19.31M
-12.04%-143.05M
-265.71%-124.59M
-114.99%-127.67M
-114.58%-83.31M
-113.26%-34.07M
-100.82%-1.09M
349.03%851.71M
218.29%571.21M
Financing cost
-15.08%-19.47M
-167.52%-12.54M
-218.62%-16.92M
-75.70%-4.69M
-51.96%-5.31M
-20.77%-3.94M
-15.45%-2.67M
-11.18%-1.35M
46.58%-3.5M
38.35%-3.26M
Share of profit from joint venture company
----
----
----
----
-83.68%-7.68M
-211.87%-7.67M
-168.51%-2.77M
---1.49M
---4.18M
---2.46M
Special items of earning before tax
89.34%-9.89M
-276.23%-5.32M
-6,715.49%-92.83M
-79.66%3.02M
-107.25%-1.36M
207.44%14.83M
9,655.26%14.83M
---26K
861.82%18.79M
207.06%4.82M
Earning before tax
67.68%-81.7M
70.57%-37.16M
-77.99%-252.8M
-411.64%-126.26M
-116.46%-142.03M
-114.04%-80.09M
-109.72%-24.68M
-103.00%-3.96M
377.58%862.83M
236.12%570.31M
Tax
-9.23%856K
-22.96%406K
-28.51%943K
117.31%527K
100.84%1.32M
97.55%-2.61M
93.58%-3.04M
84.99%-3.82M
-226.97%-157.26M
-182.43%-106.7M
After-tax profit from continuing operations
67.90%-80.84M
70.77%-36.75M
-78.99%-251.85M
-353.56%-125.73M
-119.94%-140.71M
-117.84%-82.7M
-113.43%-27.72M
-107.30%-7.78M
432.21%705.57M
251.51%463.61M
Earning after tax
67.90%-80.84M
70.77%-36.75M
-78.99%-251.85M
-353.56%-125.73M
-119.94%-140.71M
-117.84%-82.7M
-113.43%-27.72M
-107.30%-7.78M
432.21%705.57M
251.51%463.61M
Minority profit
77.54%-12.06M
89.64%-4.75M
-18.67%-53.71M
-1,758.13%-45.81M
-110.11%-45.26M
-105.50%-16.72M
-98.00%2.76M
-89.40%7.59M
295.35%447.48M
190.61%304.09M
Profit attributable to shareholders
65.29%-68.78M
59.95%-32.01M
-107.60%-198.15M
-162.16%-79.92M
-136.98%-95.45M
-141.36%-65.98M
-144.68%-30.48M
-144.01%-15.38M
1,231.37%258.09M
485.29%159.52M
Basic earnings per share
65.85%-0.07
60.24%-0.033
-107.07%-0.205
-159.38%-0.083
-136.94%-0.099
-140.96%-0.068
-145.07%-0.032
-144.44%-0.016
1,240.00%0.268
492.86%0.166
Diluted earnings per share
65.85%-0.07
60.24%-0.033
-107.07%-0.205
-159.38%-0.083
-136.94%-0.099
-140.96%-0.068
-145.07%-0.032
-144.44%-0.016
1,240.00%0.268
492.86%0.166
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
--
--
--
--
Luo Shenmei Accounting Firm
--
--
--
Luo Shenmei Accounting Firm
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover 4.25%73.5M19.79%38.87M-66.74%70.51M-82.21%32.45M-88.55%211.99M-84.27%200.71M-73.45%182.36M-66.01%130.56M196.83%1.85B152.42%1.28B
Operating income 4.25%73.5M19.79%38.87M-66.74%70.51M-82.21%32.45M-88.55%211.99M-84.27%200.71M-73.45%182.36M-66.01%130.56M196.83%1.85B152.42%1.28B
Cost of sales 12.82%-65.78M-2.18%-36.33M57.53%-75.45M70.62%-35.56M76.33%-177.66M72.05%-150.79M63.55%-121.03M58.12%-81.4M-182.45%-750.58M-154.70%-539.44M
Operating expenses 12.82%-65.78M-2.18%-36.33M57.53%-75.45M70.62%-35.56M76.33%-177.66M72.05%-150.79M63.55%-121.03M58.12%-81.4M-182.45%-750.58M-154.70%-539.44M
Gross profit 256.40%7.73M181.82%2.54M-114.39%-4.94M-105.07%-3.11M-96.88%34.32M-93.22%49.92M-82.72%61.33M-74.09%49.16M207.51%1.1B150.78%736.31M
Selling expenses 29.39%-8.31M44.56%-3.63M19.41%-11.77M10.01%-6.55M-6.44%-14.61M-4.09%-10.61M32.06%-7.28M4.74%-3.72M-17.08%-13.73M-11.87%-10.19M
Administrative expenses 40.77%-58.13M52.06%-33.98M29.06%-98.14M8.85%-70.88M42.63%-138.34M30.99%-108.73M17.12%-77.77M17.71%-44.72M-53.52%-241.16M-49.38%-157.56M
Research and development expenses 48.36%-17.2M66.09%-5.97M---33.31M---17.59M------------------------
Revaluation surplus --------------------------------453.58%2.71M--2.71M
-Changes in the fair value of financial assets --------------------------------453.58%2.71M--2.71M
Impairment and provision 104.39%30K----86.47%-684K-----195.04%-5.06M-------------582.87%-1.71M--859K
-Other impairment is provision 104.39%30K----86.47%-684K-----195.04%-5.06M-------------582.87%-1.71M--859K
Special items of operating profit 306.17%23.56M182.12%21.73M245.40%5.8M-155.63%-26.46M-185.99%-3.99M-1,403.46%-13.89M-367.33%-10.35M-807.50%-1.82M1,961.78%4.64M-311.44%-924K
Operating profit 63.42%-52.33M84.50%-19.31M-12.04%-143.05M-265.71%-124.59M-114.99%-127.67M-114.58%-83.31M-113.26%-34.07M-100.82%-1.09M349.03%851.71M218.29%571.21M
Financing cost -15.08%-19.47M-167.52%-12.54M-218.62%-16.92M-75.70%-4.69M-51.96%-5.31M-20.77%-3.94M-15.45%-2.67M-11.18%-1.35M46.58%-3.5M38.35%-3.26M
Share of profit from joint venture company -----------------83.68%-7.68M-211.87%-7.67M-168.51%-2.77M---1.49M---4.18M---2.46M
Special items of earning before tax 89.34%-9.89M-276.23%-5.32M-6,715.49%-92.83M-79.66%3.02M-107.25%-1.36M207.44%14.83M9,655.26%14.83M---26K861.82%18.79M207.06%4.82M
Earning before tax 67.68%-81.7M70.57%-37.16M-77.99%-252.8M-411.64%-126.26M-116.46%-142.03M-114.04%-80.09M-109.72%-24.68M-103.00%-3.96M377.58%862.83M236.12%570.31M
Tax -9.23%856K-22.96%406K-28.51%943K117.31%527K100.84%1.32M97.55%-2.61M93.58%-3.04M84.99%-3.82M-226.97%-157.26M-182.43%-106.7M
After-tax profit from continuing operations 67.90%-80.84M70.77%-36.75M-78.99%-251.85M-353.56%-125.73M-119.94%-140.71M-117.84%-82.7M-113.43%-27.72M-107.30%-7.78M432.21%705.57M251.51%463.61M
Earning after tax 67.90%-80.84M70.77%-36.75M-78.99%-251.85M-353.56%-125.73M-119.94%-140.71M-117.84%-82.7M-113.43%-27.72M-107.30%-7.78M432.21%705.57M251.51%463.61M
Minority profit 77.54%-12.06M89.64%-4.75M-18.67%-53.71M-1,758.13%-45.81M-110.11%-45.26M-105.50%-16.72M-98.00%2.76M-89.40%7.59M295.35%447.48M190.61%304.09M
Profit attributable to shareholders 65.29%-68.78M59.95%-32.01M-107.60%-198.15M-162.16%-79.92M-136.98%-95.45M-141.36%-65.98M-144.68%-30.48M-144.01%-15.38M1,231.37%258.09M485.29%159.52M
Basic earnings per share 65.85%-0.0760.24%-0.033-107.07%-0.205-159.38%-0.083-136.94%-0.099-140.96%-0.068-145.07%-0.032-144.44%-0.0161,240.00%0.268492.86%0.166
Diluted earnings per share 65.85%-0.0760.24%-0.033-107.07%-0.205-159.38%-0.083-136.94%-0.099-140.96%-0.068-145.07%-0.032-144.44%-0.0161,240.00%0.268492.86%0.166
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --------Unqualified Opinion------Unqualified Opinion--
Auditor --------Luo Shenmei Accounting Firm------Luo Shenmei Accounting Firm--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More